Skip to content

THC vs. CBD: What You Need to Know

THC vs. CBD: What You Need to Know

With the rising demand of natural medicines, medical marijuana compounds THC and CBD are starting to make a name for themselves more than ever before. These two compounds have a wide range of health benefits, making it understandable why patients and physicians would be interested in this alternative treatment option. Although these two compounds are derived from the same source and appear to be virtually identical, they affect the human body quite differently.

Cannabinoids and the Endocannabinoid System

Before we dissect these two compounds, it’s important to understand where they come from and what part of the body they affect. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are just two of the 85 known cannabinoids found in the Cannabis plant.

“A cannabinoid is a compound that interacts directly with our body’s Endocannabinoid System (ECS), which in short, is a network of receptors that interact with cannabinoids to maintain vital functions throughout our body.” (Medium.com/CBD-Origin).

In 1988, scientists discovered the first cannabinoid receptor, with the second coming to light in 1993. In 1995, these two receptors were identified as CB1 and CB2 receptors. “The interaction between the CB1 and CB2 receptors with cannabinoids like CBD and THC is the catalyst for health benefits such as pain relief, anxiety relief, appetite stimulation, mood management and more.”

Molecular Makeup

As far as chemical makeup goes, THC and CBD are the exact same: 21 carbon atoms, 30 hydrogen atoms and two oxygen atoms. Take a look at the figure below. The differentiator between the two compounds is the placement of one single atom through their structure. For reference, one atom is one million times smaller than a human hair, so we’re talking about a microscopic difference.

While a microscopic difference might not seem like a big deal, it’s exactly what makes these two compounds react with our body in surprisingly different ways. These different reactions are due to the fact that THC and CBD have different molecular structures, causing them to have dissimilar interactions with CB1 and CB2.

THC vs. CBD: How Each Affects the Body

Despite their near identical structures, THC and CBD differ when it comes to psychoactive effects. In fact, CBD is a non-psychoactive compound, meaning it doesn’t produce the “high” feeling associated with THC.

Due to its molecular structure, THC is able to bind strongly with CB1 receptors. When this bond is formed, the reaction creates signals that are then sent to the brain. These reactions are the core source of the well-known psychoactive response of “getting high”.

On the complete opposite side of the spectrum, CBD does not bond strongly with CB1 receptors and can even negate the bond between THC and the CB1 receptors. By doing this, those psychoactive effects induced by THC are completely neutralized.

“While THC certainly offers tremendous health benefits, its mind-altering effects aren’t preferred by everyone. CBD, on the other hand, can deliver many of the same benefits of THC without inducing its psychoactive effects. Plus, when using CBD vs THC, you typically won’t be breaking the law.” (Medium.com/CBD-Origin)

Are YOU ready to put CBD and THC to the test with your patients? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Looking for more information about CBD and THC? Check out these two articles to learn more about the health benefits and side effects:

https://medium.com/cbd-origin/cbd-vs-thc-the-difference-explained-b3cfc1da52f0

https://www.healthline.com/health/cbd-vs-thc#psychoactive-components

Stories you may be interested in

Cannabis for Treating IBD: Hope or Hype?

Nausea, abdominal pain and changes in appetite. These are all things that can significantly impact one’s wellbeing if left untreated, yet they have all shown marked improvements when associated with cannabis. Yet, less is known about the effects of cannabis on inflammatory bowel disease, or IBD, a chronic inflammatory condition that impacts the gastrointestinal tract…
Read More

Florida medical marijuana dispensary now sells the state’s first cannabis tablet

Even though Florida residents can finally smoke medical marijuana, one of the state’s largest cannabis companies is now offering it in tablet form. The company Curaleaf released the state’s first cannabis tablet on Sunday. The company’s two Orlando locations, at 775 N Semoran Blvd. and 12402 S Orange Blossom Trail, sell the mint-flavored tablets for $35 for a 30-quantity, child-resistant package. Read…
Read More

New approach to medical marijuana coming ‘very soon,’ DeSantis says

TALLAHASSEE — With one of his chief advisers tweeting the hashtag “NoSmokeIsAJoke,” Gov. Ron DeSantis said Monday he will “very soon” announce changes in how the state is carrying out a constitutional amendment that broadly legalized medical marijuana. Read the full story here.
Read More

Florida doctors face new rules for medical marijuana (And how Arfinn Med can help)

TALLAHASSEE, Fla. – New rules laying out the do’s and don’ts physicians must follow when certifying patients to smoke medical marijuana took effect last week, but it’s not clear that doctors or patients are fully aware of them. Patients certified or recertified to smoke medical marijuana must sign a new standardized consent form as of last…
Read More

The Lack of Clinical Trials in the Medical Marijuana Industry

As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More

Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois

ABSTRACT Objectives To assess health-related outcomes associated with medical cannabis use among older patients in Colorado and Illinois enrolled in their home state’s medical cannabis program. Methods Cross-sectional data from anonymous surveys were collected from 139 persons over the age of 60 using medical cannabis in the past year. We used structural equation modeling (SEM)…
Read More

Leave a Comment

You must be logged in to post a comment.